NEW YORK (GenomeWeb) – Dako, an Agilent Technologies company, today announced it has signed an additional collaboration with Amgen to develop a companion diagnostic for an unspecified Amgen cancer drug candidate.

In an email to GenomeWeb, Agilent declined to provide additional details about the agreement.

The deal builds on agreements from 2012 between the two companies, under which Dako was developing several companion diagnostics for drugs from Amgen.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in the UK and Australia uncover genetic links between BMI and depression, the Guardian reports.

The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.

The New York Times writes that natural history museums are helping round out genetic studies with older specimens.

In PNAS this week: artemisinin resistance mutations in malaria parasites, ant-plant interactions over time, and more.